Specialty Pharmaceutical Hub Services/Patient Assistance Providers News Roundup: April 2024

AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 75 companies.

Amplity Health, a leading global contract medical and commercial organization, announced that it has appointed Chris Baker to the position of Chief Executive Officer (CEO), effective immediately. Michael A. Griffith, Amplity founder and long-standing CEO, will transition to the role of Chairman of the Board of Directors as part of a deliberate succession plan. In this capacity, he will continue to support Baker and the leadership team, but with a primary focus on building the visibility and awareness of Amplity in the biopharmaceutical market. Baker joins Amplity from ICON plc where she was most recently the President of the Symphony Health division, a leading provider of high-value data, tokenization, and technology solutions for healthcare companies. Amplity Health is a contract medical and commercial organization that employs over 1,000 highly credentialed colleagues in 41 countries. Amplity delivers tailored medical and commercial solutions that scale throughout the lifecycle of a drug.

Annexus Health recently partnered with two life science companies:

• Genmab is the latest life science company to partner with Annexus Health. Healthcare organizations can enroll eligible patients in MyNavCare(once a prescribing decision has been made) directly within the AssistPoint software platform for the following: Co-pay Assistance, Benefits Verification, Prior Authorization, and Genmab Patient Assistance Program (PAP).
• Assertio partnered with Annexus Health. Healthcare organizations can now enroll eligible patients into ACCESS4ME™ for ROLVEDON^®(eflapegrastim-xnst) injection directly within the AssistPoint software platform for the following: Benefits Verification, Prior Authorization, Claims & Appeals Support, Copay Assistance, Patient Assistance Program (PAP), and Independent Charitable Foundation Information.

Annexus Health is a leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.

Pyros Pharmaceuticals, Inc. (Pyros), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, recently announced that VIGPODER (vigabatrin) for oral solution, USP, a treatment for appropriate patients with infantile spasms (IS), is now available. As a therapeutically equivalent product, VIGPODER is anticipated to offer the same safety and efficacy profile as SABRIL (vigabatrin) for oral solution. Anovo has been chosen as the exclusive distributor and specialty pharmacy for this innovative medication. Anovo goes beyond just distribution to provide support for patients, caregivers, and healthcare providers. The Anovo team will provide seamless access, personalized care and a comprehensive support system to guide caregivers through their child’s therapeutic journey.

AscellaHealth, a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance quality of life for patients with complex, chronic conditions, announced the addition of key executives to its leadership team, raising the bar and resetting standards for managing pharmacy costs through a comprehensive suite of services for regional health plans and at-risk providers. Pharmacy management solutions are fully adaptable and scalable to meet the needs of the modern payer, with core offerings that include specialty and medical cost management, formulary and network design, custom clinical programs and data analytics to assess and maximize health outcomes.

• Bob Gilkin, SVP, AscellaHealth, will design and lead the implementation of trade and specialty strategy positioning.
• Steve Seiden, VP, AscellaHealth, will architect and direct the Company’s role as program manager of specialty pharmacy programs for limited distribution drugs (LDDs).

CareMetx, a leading technology-enabled hub services platform facilitating patient access to specialty medications, announced it has acquired PX Technology, a pioneer in digitizing healthcare processes. Through the acquisition, CareMetx aims to reshape the landscape of specialty medication access and transform patient care with the fusion of its comprehensive patient support services with PX Technology’s innovative digital access technologies and network, delivering synergies and transparency across the value chain to patients, providers, and manufacturers. Founded in 2019, PX Technology leverages proprietary technology to connect patients, providers, and partners. PX Technology’s suite of digital solutions, including PX Connect, PX ePA, and PX Consent, support healthcare providers in tasks such as streamlining the patient enrollment process, offering purpose-built technology that integrates into existing native workflows and significantly reduces administrative burden.

COPILOT Provider Support Services, a leading HUB Services Provider, announced Melina Cortes-Nmili as its vice president of sales and marketing. As a senior leadership team member, Melina drives and implements sales and marketing efforts, leveraging her two decades of expertise across multiple specialty therapeutic areas. Prior to joining COPILOT, Melina served as vice president of specialty programs and consulting for Prime Therapeutics, where she rebuilt and transformed the business unit and created a client consulting offering.